| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62fe340a7025ff901d6458ae358d9efc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98f9f33e394c557047cbdbff2721fd03 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C53-128 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00 |
| filingDate |
2005-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6344f3d1f9158313940f5318cf342ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7de2bf2d8ed7f149c392c64e8fffd3d |
| publicationDate |
2007-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007083063-A1 |
| titleOfInvention |
Methods for the preparation and formulation of magnesium valproate hydrate |
| abstract |
The present invention relates to methods for preparing magnesium valproate hydrate and administering this compound to a subject in need of treatment with valproate. Pharmaceutical compositions are also provided that are useful therapies for the treatment of neurological, immunological, and viral-mediated disorders in warm-blooded mammals. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11433038-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019084038-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011015267-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11511035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10772857-B2 |
| priorityDate |
2005-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |